Cheryl Case Johnson

Everything HIV testing. Technical Officer at WHO. Views = own, RTs not endorsement.

[Cheryl Case Johnson @ccasejohn]

We need to keep access to HIV testing going and simple, low cost , quality tests are one way forward: https://t.co/GclvAEnRA9

[World Health Organization (WHO) @WHO]

Tuberculosis (TB) isn’t just something that happens ‘somewhere else’. It could affect you or someone you know.

The good news? TB is curable. Learn the signs to watch out for.

[Cheryl Case Johnson @ccasejohn]

Help WHO by giving your feedback on #multiplex testing https://t.co/dvPLD8C56v . Thank you @GlobalHep for your leadership and support! #integration @onehealth

[Unitaid @UNITAID]

According to @brookenichols at #IAS2025, self-test-based PrEP continuation could offset the costs of bespoke programming for groups like MSM and female sex workers, allowing services to be maintained even amid funding cuts.

[Unitaid @UNITAID]

Ines Dourado from @UFBA and the Unitaid-funded PrEP-1519 project emphasizes that introducing self-testing is not just a technical fix: it’s a structural opportunity to simplify PrEP delivery, expand reach and reduce the clinical burden in overstretched health systems. #IAS2025

[Unitaid @UNITAID]

Christian Stillson of @CHAI_health reminds us: HIV self-testing has evolved from a diagnostic tool to a cornerstone of PrEP access. As we scale long-acting PrEP, self-testing will be critical to reaching more people, faster and more efficiently. #IAS2025

[Unitaid @UNITAID]

According to Dr. Lloyd Mulenga, self-testing isn’t just a backup, it's central to the future of HIV prevention. By embedding it in community settings and national guidelines, Zambia is shifting how prevention reaches those most at risk. #IAS2025

[Unitaid @UNITAID]

At #IAS2025, @WHO’s Michelle Rodolph highlighted the importance of long-acting injectable PrEP, such as lenacapavir, as an added option for HIV prevention. Expanding access to more methods gives people real choice and supports better health outcomes.

[Cheryl Case Johnson @ccasejohn]

@WHO @WHO_Europe @WHOEMRO @WHOWPRO @WHOSEARO @WHOIndonesia @pahowho Great to see this out - critical to operationalize this using the WHO testing SOP to scale-up integrated testing for HIV and syphilis. Compelling results already coming out led by PNLS in DRC with just 3-months of implementation https://t.co/cNG6Jw3ScR

[Cheryl Case Johnson @ccasejohn]

@WHO @WHO_Europe @WHOEMRO @WHOWPRO @WHOSEARO @WHOIndonesia @pahowho It is critical to operationalize this approach using the WHO SOP for integration of HIV and syphilis testing for early diagnosis, treatment and care https://t.co/cNG6Jw3ScR

[World Health Organization (WHO) @WHO]

People living with HIV are at higher risk of severe #mpox. Knowing your HIV status and starting antiretroviral therapy is very important.

The new mpox guideline strongly recommends testing for HIV in people with mpox and starting antiretroviral therapy without delay.

🔗 https://t.co/zGeROZyy53

[World Health Organization (WHO) @WHO]

New guideline on the clinical management and infection prevention and control of #mpox.

This guidance is designed to support:
✅ Patients with mpox — whether at home, in the community, or in healthcare facilities
✅ The health workers and caregivers supporting them

Since the interim rapid response guidance in 2022, the mpox virus and outbreaks have continued to evolve.

This new guideline includes new and updated recommendations, grounded in the latest available evidence:
🔗 https://t.co/zGeROZyy53

[Artificial Intelligence Papers @SciFi]

Adaptive Frontier Exploration on Graphs with Applications to Network-Based Disease Testing. https://t.co/9m6rBbjat8

[Mary K Tumushime (She, Her) @MTumushime]

More cohesive communities may be better at distributing HIV self-test kits & identifying ppl with undiagnosed HIV - our findings from Zimbabwe in PLOS Global Health🗞️

https://t.co/7NSMQnlkXp

@MiriamTaegtmeye @ccasejohn @LizCorbett17 @Euphemia4 @SelfTestAfrica
#HIVSelfTest

[aidsmap @aidsmap]

This is the first of our three summary news bulletins from #CROI2025. The next one will be sent on Monday 17 March and the final one on Friday 21 March.
If you'd like to receive these bulletins as emails, and any future bulletins, sign up at: https://t.co/95PvQN1wMd

[Tedros Adhanom Ghebreyesus @DrTedros]

A great scientific signal towards another medical tool for #HIV prevention and protection.

@WHO's guidance for LEN PrEP twice-a-year dose is in development. If the trial for a yearly dose concludes successfully, WHO guidance will be rapidly adjusted.
https://t.co/7EURn2Iqtq

[Cheryl Case Johnson @ccasejohn]

Join us for World HTLV Day - 7 November 2024 for an important webinar! Register here: https://t.co/l6p4cKoteD

[The Lancet HIV @TheLancetHIV]

Since WHO recommended the global adoption of #HIV self-testing as a safe way to enhance access and uptake of testing, research indicates that self-testing can also ease #PrEP initiation and continuous usage. Explore this latest Review by Zhang and Co.
https://t.co/ROI3L3aErU

[Cheryl Case Johnson @ccasejohn]

Self-testing is important for HIV prevention. Check out our new narrative review in Lancet HIV: https://t.co/ddkE1HBG5B @HIVpxresearch @mdoherty_hiv @UNITAID @ANJSeale @SSLN_HIV @DrJasonJOng

[Tedros Adhanom Ghebreyesus @DrTedros]

Women account for 67% of the health and care workforce and yet they are still paid 24% less on average than men working in the sector: https://t.co/1xbcli6wQU

This needs to end. #EqualPayDay